カテゴリー： QYResearch, 世界, 医療/バイオ

経口高分子製剤のグローバル市場2023年：バイオ製品、タンパク質、ペプチド

◆英語タイトル：Global Oral Macromolecular Formulation Market Research Report 2023
	◆商品コード：QYR23MA8836 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2023年3月 ◆ページ数：87 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD2,900 ⇒換算￥440,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD4,350 ⇒換算￥661,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD5,800 ⇒換算￥881,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の経口高分子製剤市場について調査・分析し、世界の経口高分子製剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（バイオ製品、タンパク質、ペプチド）、用途別セグメント分析（医療リハビリテーション、ヘルスケア）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Catalent、Diabetology、UPM Pharmaceuticals、Biocon、Lubrizol、Allerganなどが含まれています。世界の経口高分子製剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、経口高分子製剤市場規模を推定する際に考慮しました。

・経口高分子製剤市場の概要
- 製品の定義
- 経口高分子製剤のタイプ別セグメント
- 世界の経口高分子製剤市場規模：タイプ別分析（バイオ製品、タンパク質、ペプチド）
- 経口高分子製剤の用途別セグメント
- 世界の経口高分子製剤市場規模：用途別分析（医療リハビリテーション、ヘルスケア）
- 世界の経口高分子製剤市場規模予測（2018年-2029年）
- 経口高分子製剤の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 経口高分子製剤市場の競争状況およびトレンド

・経口高分子製剤の地域別市場規模
- 北米の経口高分子製剤市場規模（2018年-2029年）
- アメリカの経口高分子製剤市場規模（2018年-2029年）
- ヨーロッパの経口高分子製剤市場規模（2018年-2029年）
- アジア太平洋の経口高分子製剤市場規模（2018年-2029年）
- 中国の経口高分子製剤市場規模（2018年-2029年）
- 日本の経口高分子製剤市場規模（2018年-2029年）
- 韓国の経口高分子製剤市場規模（2018年-2029年）
- インドの経口高分子製剤市場規模（2018年-2029年）
- オーストラリアの経口高分子製剤市場規模（2018年-2029年）
- 中南米の経口高分子製剤市場規模（2018年-2029年）
- 中東・アフリカの経口高分子製剤市場規模（2018年-2029年）

・タイプ別セグメント：バイオ製品、タンパク質、ペプチド
- 世界の経口高分子製剤のタイプ別販売量（2018年-2023年）
- 世界の経口高分子製剤のタイプ別売上（2018年-2023年）
- 世界の経口高分子製剤のタイプ別価格

・用途別セグメント：医療リハビリテーション、ヘルスケア
- 世界の経口高分子製剤の用途別販売量（2018年-2023年）
- 世界の経口高分子製剤の用途別売上（2018年-2023年）
- 世界の経口高分子製剤の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Catalent、Diabetology、UPM Pharmaceuticals、Biocon、Lubrizol、Allergan

・産業チェーンと販売チャネルの分析
- 経口高分子製剤産業チェーン分析
- 経口高分子製剤の主要原材料
- 経口高分子製剤の販売チャネル
- 経口高分子製剤のディストリビューター
- 経口高分子製剤の主要顧客

・経口高分子製剤市場ダイナミクス
- 経口高分子製剤の業界動向
- 経口高分子製剤市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Oral Macromolecular Formulation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oral Macromolecular Formulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oral Macromolecular Formulation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Oral Macromolecular Formulation include Catalent, Diabetology, UPM Pharmaceuticals, Biocon, Lubrizol and Allergan, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Macromolecular Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Macromolecular Formulation.
The Oral Macromolecular Formulation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral Macromolecular Formulation market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Macromolecular Formulation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Catalent
Diabetology
UPM Pharmaceuticals
Biocon
Lubrizol
Allergan
Segment by Type
Biological Products
Proteins
Peptides
Segment by Application
Medical Rehabilitation
Health Care
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Macromolecular Formulation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Macromolecular Formulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Oral Macromolecular Formulation Market Overview
1.1 Product Overview and Scope of Oral Macromolecular Formulation
1.2 Oral Macromolecular Formulation Segment by Type
1.2.1 Global Oral Macromolecular Formulation Market Value Comparison by Type (2023-2029)
1.2.2 Biological Products
1.2.3 Proteins
1.2.4 Peptides
1.3 Oral Macromolecular Formulation Segment by Application
1.3.1 Global Oral Macromolecular Formulation Market Value by Application: (2023-2029)
1.3.2 Medical Rehabilitation
1.3.3 Health Care
1.4 Global Oral Macromolecular Formulation Market Size Estimates and Forecasts
1.4.1 Global Oral Macromolecular Formulation Revenue 2018-2029
1.4.2 Global Oral Macromolecular Formulation Sales 2018-2029
1.4.3 Global Oral Macromolecular Formulation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Macromolecular Formulation Market Competition by Manufacturers
2.1 Global Oral Macromolecular Formulation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Macromolecular Formulation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Macromolecular Formulation Average Price by Manufacturers (2018-2023)
2.4 Global Oral Macromolecular Formulation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Macromolecular Formulation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Macromolecular Formulation, Product Type & Application
2.7 Oral Macromolecular Formulation Market Competitive Situation and Trends
2.7.1 Oral Macromolecular Formulation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Macromolecular Formulation Players Market Share by Revenue
2.7.3 Global Oral Macromolecular Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Macromolecular Formulation Retrospective Market Scenario by Region
3.1 Global Oral Macromolecular Formulation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Macromolecular Formulation Global Oral Macromolecular Formulation Sales by Region: 2018-2029
3.2.1 Global Oral Macromolecular Formulation Sales by Region: 2018-2023
3.2.2 Global Oral Macromolecular Formulation Sales by Region: 2024-2029
3.3 Global Oral Macromolecular Formulation Global Oral Macromolecular Formulation Revenue by Region: 2018-2029
3.3.1 Global Oral Macromolecular Formulation Revenue by Region: 2018-2023
3.3.2 Global Oral Macromolecular Formulation Revenue by Region: 2024-2029
3.4 North America Oral Macromolecular Formulation Market Facts & Figures by Country
3.4.1 North America Oral Macromolecular Formulation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Macromolecular Formulation Sales by Country (2018-2029)
3.4.3 North America Oral Macromolecular Formulation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Macromolecular Formulation Market Facts & Figures by Country
3.5.1 Europe Oral Macromolecular Formulation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Macromolecular Formulation Sales by Country (2018-2029)
3.5.3 Europe Oral Macromolecular Formulation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Macromolecular Formulation Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Macromolecular Formulation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Macromolecular Formulation Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Macromolecular Formulation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Macromolecular Formulation Market Facts & Figures by Country
3.7.1 Latin America Oral Macromolecular Formulation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Macromolecular Formulation Sales by Country (2018-2029)
3.7.3 Latin America Oral Macromolecular Formulation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Macromolecular Formulation Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Macromolecular Formulation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Macromolecular Formulation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Macromolecular Formulation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Macromolecular Formulation Sales by Type (2018-2029)
4.1.1 Global Oral Macromolecular Formulation Sales by Type (2018-2023)
4.1.2 Global Oral Macromolecular Formulation Sales by Type (2024-2029)
4.1.3 Global Oral Macromolecular Formulation Sales Market Share by Type (2018-2029)
4.2 Global Oral Macromolecular Formulation Revenue by Type (2018-2029)
4.2.1 Global Oral Macromolecular Formulation Revenue by Type (2018-2023)
4.2.2 Global Oral Macromolecular Formulation Revenue by Type (2024-2029)
4.2.3 Global Oral Macromolecular Formulation Revenue Market Share by Type (2018-2029)
4.3 Global Oral Macromolecular Formulation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Macromolecular Formulation Sales by Application (2018-2029)
5.1.1 Global Oral Macromolecular Formulation Sales by Application (2018-2023)
5.1.2 Global Oral Macromolecular Formulation Sales by Application (2024-2029)
5.1.3 Global Oral Macromolecular Formulation Sales Market Share by Application (2018-2029)
5.2 Global Oral Macromolecular Formulation Revenue by Application (2018-2029)
5.2.1 Global Oral Macromolecular Formulation Revenue by Application (2018-2023)
5.2.2 Global Oral Macromolecular Formulation Revenue by Application (2024-2029)
5.2.3 Global Oral Macromolecular Formulation Revenue Market Share by Application (2018-2029)
5.3 Global Oral Macromolecular Formulation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Catalent
6.1.1 Catalent Corporation Information
6.1.2 Catalent Description and Business Overview
6.1.3 Catalent Oral Macromolecular Formulation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Catalent Oral Macromolecular Formulation Product Portfolio
6.1.5 Catalent Recent Developments/Updates
6.2 Diabetology
6.2.1 Diabetology Corporation Information
6.2.2 Diabetology Description and Business Overview
6.2.3 Diabetology Oral Macromolecular Formulation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Diabetology Oral Macromolecular Formulation Product Portfolio
6.2.5 Diabetology Recent Developments/Updates
6.3 UPM Pharmaceuticals
6.3.1 UPM Pharmaceuticals Corporation Information
6.3.2 UPM Pharmaceuticals Description and Business Overview
6.3.3 UPM Pharmaceuticals Oral Macromolecular Formulation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 UPM Pharmaceuticals Oral Macromolecular Formulation Product Portfolio
6.3.5 UPM Pharmaceuticals Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Corporation Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Oral Macromolecular Formulation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocon Oral Macromolecular Formulation Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Lubrizol
6.5.1 Lubrizol Corporation Information
6.5.2 Lubrizol Description and Business Overview
6.5.3 Lubrizol Oral Macromolecular Formulation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lubrizol Oral Macromolecular Formulation Product Portfolio
6.5.5 Lubrizol Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Oral Macromolecular Formulation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Allergan Oral Macromolecular Formulation Product Portfolio
6.6.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Macromolecular Formulation Industry Chain Analysis
7.2 Oral Macromolecular Formulation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Macromolecular Formulation Production Mode & Process
7.4 Oral Macromolecular Formulation Sales and Marketing
7.4.1 Oral Macromolecular Formulation Sales Channels
7.4.2 Oral Macromolecular Formulation Distributors
7.5 Oral Macromolecular Formulation Customers
8 Oral Macromolecular Formulation Market Dynamics
8.1 Oral Macromolecular Formulation Industry Trends
8.2 Oral Macromolecular Formulation Market Drivers
8.3 Oral Macromolecular Formulation Market Challenges
8.4 Oral Macromolecular Formulation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経口高分子製剤のグローバル市場2023年：バイオ製品、タンパク質、ペプチド(Global Oral Macromolecular Formulation Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

経口高分子製剤のグローバル市場2023年：バイオ製品、タンパク質、ペプチド

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp